CAV-3 is a novel Long QT syndrome (LQTS)-associated gene with mutations producing a gain-of-function, LQT3-like molecular/cellular phenotype, as a pathogenic basis of sudden infant death syndrome (SIDS) [25]. The gene discussed is CAV3; the disease is sudden infant death syndrome.